Olivier Binda

Dr. Olivier Binda

Université Claude Bernard Lyon 1 / University of Ottawa (Visiting Scientist)

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2009 in Molecular Cell
Verified
Journal Article
Closed access
THTiffany Hung
Tiffany Hung
OBOlivier Binda
Olivier Binda
KCKaren S. Champagne
Karen S. Champagne
AKAlex J. Kuo
Alex J. Kuo
KJKyle Johnson
Kyle Johnson
OGOr Gozani
Or Gozani

1 July 2010 in Molecular Cell
Verified
Journal Article
Closed access
Jason S. LeeJason S. Lee
Jason S. Lee
YKYunho Kim
Yunho Kim
IKIk Soo Kim
Ik Soo Kim
BKBogyou Kim
Bogyou Kim
HCHee June Choi
Hee June Choi
SBSung Hee Baek
Sung Hee Baek

8 August 2011 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
Jason S. LeeJason S. Lee
Jason S. Lee
YKYunho Kim
Yunho Kim
JBJinhyuk Bhin
Jinhyuk Bhin
HSHi-Jai R. Shin
Hi-Jai R. Shin
HNHye Jin Nam
Hye Jin Nam
SBSung Hee Baek
Sung Hee Baek
Pontin is a chromatin remodeling factor that possesses both ATPase and DNA helicase activities. Although Pontin is frequently overexpressed in human cancers of various types and implicated in oncogenic functions, the upstream signaling network leading to the regulation of Pontin that in turn affects transcription of downstream target genes has not been extensively studied. Here, we identify Pontin is methylated by G9a/GLP methyltransferases in hypoxic condition and potentiates HIF-1α-mediated activation by increasing the recruitment of p300 coactivator to a subset of HIF-1α target promoters. Intriguingly, Pontin methylation results in the increased invasive and migratory properties by activating downstream target gene, Ets1 . In contrast, inhibition of Pontin methylation results in the suppression of tumorigenic and metastatic properties. Together, our data provide new approaches by targeting Pontin methylation and its downstream targets for the development of therapeutic agents for human cancers.

20 September 2018 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
CCCamille Cohen
Camille Cohen
ACArmelle Corpet
Armelle Corpet
SRSimon Roubille
Simon Roubille
MMMohamed Ali Maroui
Mohamed Ali Maroui
NPNolwenn Poccardi
Nolwenn Poccardi
PLPatrick Lomonte
Patrick Lomonte
Herpes simplex virus 1 (HSV-1) latency establishment is tightly controlled by promyelocytic leukemia (PML) nuclear bodies (NBs) (or ND10), although their exact contribution is still elusive. A hallmark of HSV-1 latency is the interaction between latent viral genomes and PML NBs, leading to the formation of viral DNA-containing PML NBs (vDCP NBs), and the complete silencing of HSV-1. Using a replication-defective HSV-1-infected human primary fibroblast model reproducing the formation of vDCP NBs, combined with an immuno-FISH approach developed to detect latent/quiescent HSV-1, we show that vDCP NBs contain both histone H3.3 and its chaperone complexes, i.e., DAXX/ATRX and HIRA complex (HIRA, UBN1, CABIN1, and ASF1a). HIRA also co-localizes with vDCP NBs present in trigeminal ganglia (TG) neurons from HSV-1-infected wild type mice. ChIP and Re-ChIP show that vDCP NBs-associated latent/quiescent viral genomes are chromatinized almost exclusively with H3.3 modified on its lysine (K) 9 by trimethylation, consistent with an interaction of the H3.3 chaperones with multiple viral loci and with the transcriptional silencing of HSV-1. Only simultaneous inactivation of both H3.3 chaperone complexes has a significant impact on the deposition of H3.3 on viral genomes, suggesting a compensation mechanism. In contrast, the sole depletion of PML significantly impacts the chromatinization of the latent/quiescent viral genomes with H3.3 without any overall replacement with H3.1. vDCP NBs-associated HSV-1 genomes are not definitively silenced since the destabilization of vDCP NBs by ICP0, which is essential for HSV-1 reactivation in vivo, allows the recovery of a transcriptional lytic program and the replication of viral genomes. Consequently, the present study demonstrates a specific chromatin regulation of vDCP NBs-associated latent/quiescent HSV-1 through an H3.3-dependent HSV-1 chromatinization involving the two H3.3 chaperones DAXX/ATRX and HIRA complexes. Additionally, the study reveals that PML NBs are major actors in latent/quiescent HSV-1 H3.3 chromatinization through a PML NB/histone H3.3/H3.3 chaperone axis. An understanding of the molecular mechanisms contributing to the persistence of a virus in its host is essential to be able to control viral reactivation and its associated diseases. Herpes simplex virus 1 (HSV-1) is a human pathogen that remains latent in the PNS and CNS of the infected host. The latency is unstable, and frequent reactivations of the virus are responsible for PNS and CNS pathologies. It is thus crucial to understand the physiological, immunological and molecular levels of interplay between latent HSV-1 and the host. Promyelocytic leukemia (PML) nuclear bodies (NBs) control viral infections by preventing the onset of lytic infection. In previous studies, we showed a major role of PML NBs in favoring the establishment of a latent state for HSV-1. A hallmark of HSV-1 latency establishment is the formation of PML NBs containing the viral genome, which we called “viral DNA-containing PML NBs” (vDCP NBs). The genome entrapped in the vDCP NBs is transcriptionally silenced. This naturally occurring latent/quiescent state could, however, be transcriptionally reactivated. Therefore, understanding the role of PML NBs in controlling the establishment of HSV-1 latency and its reactivation is essential to design new therapeutic approaches based on the prevention of viral reactivation.

1 February 2013 in Epigenetics
Verified
Journal Article
Open access
PDF file
OBOlivier Binda
Olivier Binda
Ana SevillaAna Sevilla
Ana Sevilla
GLGary LeRoy
Gary LeRoy
ILIhor R. Lemischka
Ihor R. Lemischka
BGBenjamin A. Garcia
Benjamin A. Garcia
SRStéphane Richard
Stéphane Richard
The histone H2A variant H2AZ is an essential chromatin signaling factor. Herein, we report that H2AZ is monomethylated at lysine 7 (H2AZK7me1) by the lysine methyltransferase SETD6. We observed that methylation of H2AZ increased noticeably upon cellular differentiation of mouse embryonic stem cells (mESCs). H2AZK7me1 and the repressive H3K27me3 mark were found near the transcriptional start sites of differentiation marker genes, but were removed upon retinoic acid-induced cellular differentiation. The depletion of Setd6 in mESCs led to cellular differentiation, compromised self-renewal, and poor clonogenicity. These findings demonstrate that mESCs require Setd6 for self-renewal and portray H2AZK7me1 as a marker of cellular differentiation.

1 November 2010 in Epigenetics
Verified
Journal Article
Closed access
OBOlivier Binda
Olivier Binda
GLGary LeRoy
Gary LeRoy
DBDennis J. Bua
Dennis J. Bua
BGBenjamin A. Garcia
Benjamin A. Garcia
OGOr Gozani
Or Gozani
SRStéphane Richard
Stéphane Richard
Chromatin is broadly compartmentalized in two defined states: euchromatin and heterochromatin. Generally, euchromatin is trimethylated on histone H3 lysine 4 (H3K4me3) while heterochromatin contain...